DTPw-HBV/Hib-MenAC conjugate vaccine
759346
Phase 2 mab completed
Quick answer
DTPw-HBV/Hib-MenAC conjugate vaccine for Diphtheria is a Phase 2 program (mab) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Diphtheria
- Phase
- Phase 2
- Modality
- mab
- Status
- completed